Lunai Bioworks LNAI
NASDAQ LNAI
$1.77 -0.07 (-3.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) EBIT Margin (2013 - 2026)

Updated

Lunai Bioworks (LNAI) recorded EBIT Margin of -7054.05% in fiscal Q3 2026 (quarter ended Mar 31, 2026).

Analysis

Lunai Bioworks (LNAI) EBIT Margin (2013 - 2026) Analysis & Trends

On a TTM basis, Lunai Bioworks' EBIT Margin came in at -156672.97% as of Mar 31, 2026; for FY2016 (ended Jun 30, 2016), it was -4959.04%.

  • Annual EBIT Margin has a four-year change of -1895.59 percentage points (FY2012 to FY2016).
  • Across earlier fiscal years, EBIT Margin came in at -2201.85% in FY2015, -5306.85% in FY2013 (-2243.40 pp) and -3063.45% in FY2012.
  • The fiscal Q3 2026 figure is the highest quarterly EBIT Margin since fiscal Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Lunai Bioworks 5.81 Mn 1.06 Mn 20,942.00 -7,054.05%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -7,054.05%
Dec 31, 2015 -1,399.04%
Sep 30, 2013 -36,676.86%
Mar 31, 2013 -571.85%
API Access

Lunai Bioworks EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=LNAI&period=max&api_key=YOUR_API_KEY